Shipp MA - Search Results

1

Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma.

Carey CD, Gusenleitner D, Lipschitz M, Roemer MGM, Stack EC, Gjini E, Hu X, Redd R, Freeman GJ, Neuberg D, Hodi FS, Liu XS, Shipp MA, Rodig SJ. Carey CD, et al. Among authors: shipp ma. Blood. 2017 Nov 30;130(22):2420-2430. doi: 10.1182/blood-2017-03-770719. Epub 2017 Sep 11. Blood. 2017. PMID: 28893733 Free PMC article.

2

Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements.

Ishimaru F, Shipp MA. Ishimaru F, et al. Among authors: shipp ma. Blood. 1995 Jun 1;85(11):3199-207. Blood. 1995. PMID: 7756651 Free article.

3

Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?

Shipp MA. Shipp MA. Blood. 1994 Mar 1;83(5):1165-73. Blood. 1994. PMID: 8118021 Free article. Review.

4

High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study.

Shipp MA, Neuberg D, Janicek M, Canellos GP, Shulman LN. Shipp MA, et al. J Clin Oncol. 1995 Dec;13(12):2916-23. doi: 10.1200/JCO.1995.13.12.2916. J Clin Oncol. 1995. PMID: 8523055

5

CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase.

Ganju RK, Shpektor RG, Brenner DG, Shipp MA. Ganju RK, et al. Among authors: shipp ma. Blood. 1996 Dec 1;88(11):4159-65. Blood. 1996. PMID: 8943850 Free article.

6

Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.

Janicek M, Kaplan W, Neuberg D, Canellos GP, Shulman LN, Shipp MA. Janicek M, et al. Among authors: shipp ma. J Clin Oncol. 1997 Apr;15(4):1631-7. doi: 10.1200/JCO.1997.15.4.1631. J Clin Oncol. 1997. PMID: 9193363

7

A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma.

Yakushijin Y, Steckel J, Kharbanda S, Hasserjian R, Neuberg D, Jiang W, Anderson I, Shipp MA. Yakushijin Y, et al. Among authors: shipp ma. Blood. 1998 Jun 1;91(11):4282-91. Blood. 1998. PMID: 9596677 Free article.

8

PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes G0/G1 arrest.

Aguiar RC, Yakushijin Y, Kharbanda S, Tiwari S, Freeman GJ, Shipp MA. Aguiar RC, et al. Among authors: shipp ma. Blood. 1999 Oct 1;94(7):2403-13. Blood. 1999. PMID: 10498613 Free article.

9

BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration.

Aguiar RC, Yakushijin Y, Kharbanda S, Salgia R, Fletcher JA, Shipp MA. Aguiar RC, et al. Among authors: shipp ma. Blood. 2000 Dec 15;96(13):4328-34. Blood. 2000. PMID: 11110709 Free article.

10

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival.

Howard OM, Gribben JG, Neuberg DS, Grossbard M, Poor C, Janicek MJ, Shipp MA. Howard OM, et al. Among authors: shipp ma. J Clin Oncol. 2002 Mar 1;20(5):1288-94. doi: 10.1200/JCO.2002.20.5.1288. J Clin Oncol. 2002. PMID: 11870171 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters